Remdesivir-associated bradycardia

被引：14

作者：

Ching, Patrick R. ^{[1
]}

Lee, Calvin ^{[2
]}

机构：

[1] Univ Maryland, Med Ctr, Dept Med, Midtown Campus, Baltimore, MD 21201 USA

[2] Univ Maryland, Sch Med, Dept Med, Div Cardiovasc Med, Baltimore, MD 21201 USA

来源：

BMJ CASE REPORTS | 2021年 / 14卷 / 09期

关键词：

cardiovascular medicine; COVID-19; infectious diseases; drugs and medicines;

D O I：

10.1136/bcr-2021-245289

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Remdesivir is an antiviral used for the treatment of COVID-19 requiring hospitalisation. Information on its cardiovascular safety profile is scarce. We report the case of a 37-year-old man with COVID-19 who developed bradycardia after receiving remdesivir. We recommend a baseline ECG for all patients prior to receiving remdesivir and continuous cardiac monitoring during treatment, especially among those with underlying cardiovascular disease, elderly and using beta-blockers.

引用

页数：2

共 10 条

[1] Sinus Bradycardia Associated with Remdesivir Treatment in COVID-19: A Case Report and Literature Review [J].

Barkas, Fotios ;

Styla, Chrysoula-Paraskevi ;

Bechlioulis, Aris ;

Milionis, Haralampos ;

Liberopoulos, Evangelos .

JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2021, 8 (02)

[2]

Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI [10.1056/NEJMoa2007764, 10.1056/NEJMc2022236]

[3] Bradycardia associated with remdesivir therapy for COVID-19 in a 59-year-old man [J].

Day, Leora Branfield ;

Abdel-Qadir, Husam ;

Fralick, Michael .

CANADIAN MEDICAL ASSOCIATION JOURNAL, 2021, 193 (17) :E612-E615

[4] Safety profile of the antiviral drug remdesivir: An update [J].

Fan, Qianqian ;

Zhang, Bo ;

Ma, Jie ;

Zhang, Shuyang .

BIOMEDICINE & PHARMACOTHERAPY, 2020, 130

[5] Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency [J].

Gordon, Calvin J. ;

Tchesnokov, Egor P. ;

Woolner, Emma ;

Perry, Jason K. ;

Feng, Joy Y. ;

Porter, Danielle P. ;

Gotte, Matthias .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2020, 295 (20) :6785-6797

[6] Compassionate Use of Remdesivir for Patients with Severe Covid-19 [J].

Grein, J. ;

Ohmagari, N. ;

Shin, D. ;

Diaz, G. ;

Asperges, E. ;

Castagna, A. ;

Feldt, T. ;

Green, G. ;

Green, M. L. ;

Lescure, F-X ;

Nicastri, E. ;

Oda, R. ;

Yo, K. ;

Quiros-Roldan, E. ;

Studemeister, A. ;

Redinski, J. ;

Ahmed, S. ;

Bernett, J. ;

Chelliah, D. ;

Chen, D. ;

Chihara, S. ;

Cohen, S. H. ;

Cunningham, J. ;

Monforte, A. DArminio ;

Ismail, S. ;

Kato, H. ;

Lapadula, G. ;

L'Her, E. ;

Maeno, T. ;

Majumder, S. ;

Massari, M. ;

Mora-Rillo, M. ;

Mutoh, Y. ;

Nguyen, D. ;

Verweij, E. ;

Zoufaly, A. ;

Osinusi, A. O. ;

DeZure, A. ;

Zhao, Y. ;

Zhong, L. ;

Chokkalingam, A. ;

Elboudwarej, E. ;

Telep, L. ;

Timbs, L. ;

Henne, I ;

Sellers, S. ;

Cao, H. ;

Tan, S. K. ;

Winterbourne, L. ;

Desai, P. .

NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (24) :2327-2336

[7]

Gubitosa James C, 2020, JACC Case Rep, V2, P2260, DOI 10.1016/j.jaccas.2020.08.025

[8] Cardiac Adverse Events With Remdesivir in COVID-19 Infection [J].

Gupta, Anupam K. ;

Parker, Barbara M. ;

Priyadarshi, Vikash ;

Parker, John .

CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (10)

[9] The Mechanism of the Negative Chronotropic and Dromotropic Actions of Adenosine 5′-triphosphate in the Heart: An Update [J].

Pelleg, Amir ;

Belhassen, Bernard .

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2010, 56 (01) :106-109

[10] Serious bradycardia and remdesivir for coronavirus 2019 (COVID-19): a new safety concerns [J].

Touafchia, Anthony ;

Bagheri, Haleh ;

Carrie, Didier ;

Durrieu, Genevieve ;

Sommet, Agnes ;

Chouchana, Laurent ;

Montastruc, Francois .

CLINICAL MICROBIOLOGY AND INFECTION, 2021, 27 (05) :791.e5-791.e8

← 1 →